An Australian-first study demonstrating the effectiveness of a new immunization against respiratory syncytial virus (RSV) for ...

Starting this spring, the Respiratory Syncytial Virus (RSV) vaccine will be available to adults aged 60 years and older residing in congregate living facilities, such as long-term care homes and ...

The bivalent respiratory syncytial virus prefusion F vaccine is highly effective and well tolerated against RSV-associated ...

Abrysvo, which is now the first maternal RSV vaccine to be prequalified by the organisation, aims to prevent RSV-associated ...

The rollout of a vaccine for respiratory syncytial virus (RSV) has slashed hospital admissions by 30% among older people, ...

A single dose of respiratory syncytial virus vaccine was effective against infections and associated hospitalizations in veterans aged at least 60 years during the 2023-24 season.

Historically, RSV has been studied mainly in infants and older adults, but recent research shows that it also poses a ...

Kelly Osbourne has opened up about a health scare that saw her hooked up to an assisted breathing machine. The 40-year-old, ...

Early data suggests that the respiratory syncytial virus (RSV) vaccination programme is significantly reducing hospital admissions among ...

In primary care settings, the burden of RSV on young children and their guardians often varied between the countries of ...

Kelly Osbourne has opened up about a health scare that saw her hooked up to an assisted breathing machine. The 40-year-old, ...